[Caffeine. Physiological and pharmacological aspects].
Nørager
Charlotte Buchard
CB
Herning Sygehus, Kirurgisk Forskningsafdeling.
Jensen
Martin Bach
MB
Madsen
Mogens Røbaek
MR
D002110:Caffeine / Q000378:metabolism / Q000494:pharmacology*; D000697:Central Nervous System Stimulants / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D018482:Muscle, Skeletal / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D010807:Physical Endurance / Q000187:drug effects; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1 / Q000187:drug effects / Q000378:metabolism
D000697:Central Nervous System Stimulants; D010726:Phosphodiesterase Inhibitors; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1; D002110:Caffeine